Department of Medical Microbiology and Immunology.
Department of Internal Medicine, Division of Infectious Diseases, University of California, Davis Medical Center.
Clin Infect Dis. 2017 Jul 15;65(2):338-341. doi: 10.1093/cid/cix318.
Coccidioidal meningitis (CM) has high morbidity, and adjunctive measures to improve outcomes are needed. Using an established multicenter retrospective cohort study of CM (N = 221), we found that patients receiving adjunctive corticosteroids had a significant reduction in secondary cerebrovascular events (P = .0049). Those with CM-associated cerebrovascular events (8%) may benefit from short-term corticosteroids.
球孢子菌性脑膜炎(CM)发病率高,需要辅助措施来改善预后。本研究使用了一项已建立的多中心回顾性 CM 队列研究(N=221),发现接受辅助皮质类固醇治疗的患者继发性脑血管事件显著减少(P=0.0049)。伴有 CM 相关脑血管事件(8%)的患者可能从短期皮质类固醇治疗中获益。